Coronary artery disease (CAD)
Conditions
Interventions
calcium channel blockers (CCBs)
Beta blockers
Sponsors
Keio University, School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with stable/unstable angina or silent ischemia who underwent PCI with everolimus eluting stent. 2.Single vessel disease with deployment of 3 stents or less. 3.Patients must be 20 years of age or more.
Exclusion criteria
Exclusion criteria: 1.Stent restenosis or previous bypass surgery. 2.Previous diagnosis of vasospasmic angina within 1 years and/or on treatment. 3.Previous PCI within 1 years. 4.An event of acute myocardial infarction within 7 days. 5.Left main disease. 6.Left ventricular ejection fraction of less than 35%. 7.Previous Pacemaker Implant or AV block of more than 1st degree. 8.SBP less than 100 or HR less than 60 prior to PCI. 9.Renal failure (Cr more than 2.0mg/dl or on hemodialysis) 10.Liver failure (eg. cirrhosis) 11.Reversible obstructive lung disease 12.Diagnosis of malignancy within 5 years 13.Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence of Acetylcholine induced coronary vasospasm 9 month after PCI | — |
Secondary
| Measure | Time frame |
|---|---|
| All cause death MACEE: acute myocardial infarction, stable or unstable angina, any coronary revascularization procedure, or cerebrovascular accident | — |
Countries
Japan
Contacts
Public ContactShun Kohsaka
Keio University, School of Medicine Division of Cardiology
Outcome results
None listed